Theralase Technologies Inc (TSX-V:TLT, OTCQB:TLTFF) has closed a non-brokered private placement, issuing 6,666,670 units at C$0.18 per unit, totaling approximately $1.2 million.
Each unit includes one common share and one warrant. The warrants allow purchase of additional shares at $0.25 per share for five years. Proceeds will support Phase II NMIBC clinical study, Rutherrin development, and general corporate purposes.
The company paid a broker's fee of $1,500 and issued 4,166 non-transferrable broker warrants.